SRF UK are fundraising in partnership with SRF US & EU to further develop an AAV gene therapy to restore normal SynGAP levels. This therapy will be tested in established rat models of SYNGAP1. Profs Cobb and Kind are considered leaders in this field.
Story
Join us in fundraising to further develop an AAV gene therapy for SYNGAP1!